Current Edition

Aduhelm

Biogen piles on more long-term Aduhelm data, linking biomarker to Alzheimer’s clinical benefit

Despite a disastrous commercial rollout, Biogen is still producing longer-term data for beleaguered Alzheimer’s disease therapy Aduhelm. In patients who’ve been treated with Aduhelm for …

Continue Reading →
biomarker

Recent Advances and Future Challenges Using Biomarkers in Oncology Precision Medicine

Current and future cancer treatment is expected to be shaped and guided by the use of biomarkers that will guide researchers and physicians at every …

Continue Reading →
ALS

MediciNova Announces Full Enrollment in ALS Biomarker Clinical Trial

MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number:4875), today announced …

Continue Reading →
biomarker

Proteomics and Dimerix partner to improve the treatment of kidney disease

Australia-based Proteomics International (PI) has developed PromarkerD, a predictive and diagnostic test for diabetic kidney disease that measures a protein biomarker panel in the blood. …

Continue Reading →
biomarker

New Swedish study results at SABCS show DiviTum ® blood test reduces waiting times for evaluating breast cancer treatment

Results from a study of 142 women with newly diagnosed metastatic breast cancer will be presented by researchers from Lund University at the world’s biggest …

Continue Reading →